Media

Avexis data integrity

Novartis stands behind Zolgensma® for the treatment of children less than 2 years of age with spinal muscular atrophy.

Updates

Novartis Financial Results – Q2 2019

Novartis announced the company’s financial results for the second quarter and first half of 2019.

Video - Novartis Financial Results

Our Executive Team talks about innovation highlights from the second quarter of 2019.

Watch video

Latest media releases

Sep 13, 2019

Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Sep 13, 2019

New Novartis data show that neuronal and glial filaments, biomarkers of disease activity, have the potential to support decision making in the management of multiple sclerosis (MS) patient
Sep 12, 2019

New Novartis data show Mayzent® can help preserve mobility for longer in patients with secondary progressive multiple sclerosis (SPMS)
Sep 10, 2019

Novartis data at ECTRIMS to highlight innovative approach to reimagining care for people living with multiple sclerosis (MS)

News archive

Subscribe to media releases

Resources

Media Library

Browse and download multimedia resources including images, videos, infographics and more.

Visit the Media Library

Novartis Annual Review 2018

The Annual Review, our new corporate report, explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2018.

Read the Annual Review

A healthcare professional speaks to a patient

Corporate Responsibility

Learn more about our Corporate Responsibility strategy and access resources including the annual Novartis in Society Report

Learn more

Corporate Fact Sheets

The fact sheets provide a comprehensive overview of Novartis overall as well as our divisions and our research organization. It also outlines our commitment to associates and to corporate responsibility.

View Fact Sheets

Social media